Pinebridge Investments L.P. Boosts Position in Humana Inc. (NYSE:HUM)

Pinebridge Investments L.P. lifted its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 28.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 13,383 shares of the insurance provider's stock after purchasing an additional 3,000 shares during the period. Pinebridge Investments L.P.'s holdings in Humana were worth $3,395,000 as of its most recent filing with the SEC.

Other large investors also recently added to or reduced their stakes in the company. Transcend Capital Advisors LLC grew its stake in shares of Humana by 399.7% during the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock valued at $924,000 after buying an additional 2,914 shares during the last quarter. FNY Investment Advisers LLC grew its position in Humana by 6,647.5% during the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock worth $6,916,000 after acquiring an additional 26,856 shares during the last quarter. Retirement Systems of Alabama increased its stake in Humana by 735.9% in the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock worth $55,563,000 after purchasing an additional 192,801 shares during the period. Charles Schwab Investment Management Inc. lifted its position in Humana by 7.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock valued at $244,811,000 after purchasing an additional 65,735 shares during the last quarter. Finally, Secure Asset Management LLC bought a new stake in Humana in the fourth quarter valued at approximately $244,000. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Stock Down 1.6 %

Shares of Humana stock traded down $4.29 during midday trading on Tuesday, hitting $258.91. The company had a trading volume of 2,471,973 shares, compared to its average volume of 1,749,990. The company has a 50 day moving average of $266.31 and a 200 day moving average of $270.84. The stock has a market capitalization of $31.25 billion, a P/E ratio of 26.02, a P/E/G ratio of 2.05 and a beta of 0.62. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, equities analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 annualized dividend and a yield of 1.37%. Humana's dividend payout ratio (DPR) is presently 35.58%.

Analysts Set New Price Targets

Several brokerages recently commented on HUM. Truist Financial lifted their target price on shares of Humana from $290.00 to $325.00 and gave the stock a "hold" rating in a research note on Friday, April 11th. Robert W. Baird boosted their price objective on shares of Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a research report on Tuesday, April 15th. Guggenheim initiated coverage on shares of Humana in a report on Wednesday, April 9th. They set a "buy" rating and a $326.00 target price for the company. Mizuho boosted their price target on Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Finally, Cantor Fitzgerald reaffirmed a "neutral" rating and set a $290.00 price target on shares of Humana in a research report on Wednesday, February 12th. Seventeen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $284.90.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.